Celldex Q4 Loss Per Share Unchanged - Quick Facts

(RTTNews) - Celldex Therapeutics Inc. (CLDX) Monday reported a net loss of $22.06 million or $0.27 per share for the fourth quarter of 2013 compared to net loss of $16.81 million, or $0.27 per share for the same quarter last year.

On average, 8 analysts polled by Thomson Reuters expected a loss of $0.28 per share for the quarter. Analysts' estimates typically exclude special items.

Total revenue declined to $620 thousand in the fourth quarter of 2013 from $3.6 million in the prior year that included $3.55 million in product royalties. Analysts expected revenues of $270 thousand for the quarter.

Celldex expects that its cash, cash equivalents and marketable securities will be sufficient to fund its operating expenses and capital expenditure requirements through 2016.

CLDX, which closed down 7.5 percent on Friday at $29.22, is falling 5.9 percent in pre-market activity.